Digital twins are virtual representations of an object or system that spans its lifecycle, is updated from real-time data, and use simulation, machine learning and reasoning to help decision-making (IBM). In most cases, this helps data scientists understand how products are operating in production environments and anticipate how they may behave overtime. But what happens when a digital twin is that of a human being? By using digital twins to model a person, you can use technologies like
Read More
genomics
Epic Integrates Caris Molecular Testing Portfolio with Epic’s ORA Network
What You Should Know: - Caris Life Sciences (Caris), the leading molecular science and technology company today announced an enhanced partnership with Epic to integrate Caris' market-leading molecular testing portfolio with Epic's Orders and Results Anywhere (ORA) network. - Caris builds upon its current Genomics Module integration within the nation's largest electronic health record provider by offering seamless ordering and receipt of Caris molecular profiling results directly in patient
Read More
Syapse and Pierian Partner to Power Precision Oncology
What You Should Know: - Syapse, a real-world evidence company is teaming up with Pierian®, a provider of advanced clinical genomics technology on a new joint collaboration that will benefit patients of the AdventHealth Cancer Institute in Central Florida. - The collaboration combines Syapse’s real-world evidence solutions designed to improve outcomes for patients with cancer, Pierian’s leading-edge clinical genomics workflow, and precision medicine services that provide the most relevant
Read More
C2i Genomics, Karkinos Healthcare Partner to Bring AI-Powered Cancer R&D to India
What You Should Know: - C2i Genomics, a cancer intelligence company, announced a strategic partnership with Karkinos Healthcare to develop the first whole-genome sequencing (WGS) MRD test that will further R&D efforts in India. - This partnership will improve diagnostic labs in India by providing them with the ability to validate and monitor the quality of whole-genome cancer screening and minimal residual disease (MRD) products faster. AI-Powered Cancer Detection and Monitoring
Read More
Watchmaker Genomics Raises $40M to Expand Clinical Sequencing Product Offerings
What You Should Know: - Watchmaker Genomics, a life sciences company specializing in the development of high-stringency applications focused on the reading, writing, and editing of DNA and RNA raises $40M in an oversubscribed Series A, bringing total funding to date to $53.5M. The round was led by Decheng Capital, with co-investment from Eclipse Ventures. - Watchmaker Genomics applies advanced enzymology to enable breakthrough applications for the reading, writing, and
Read More
Character Biosciences Raises $18M to Expand Precision Medicine Platform for Diseases of Aging
What You Should Know: - Character Biosciences (“Character”), a precision medicine platform for diseases of aging raises $18M in a new funding round led by Innovation Endeavors, alongside leading life sciences investors Section 32 and Catalio Capital Management. Formerly known as Clover Therapeutics, the company’s data-driven approach integrates genomics, deep phenotyping and machine learning for target and biomarker discovery. - The company will use the funding to advance the frontiers of
Read More
Imagene Raises $21.5M to Expand Image-Based Biomarker Detection for Precision Medicine
What You Should Know: - Imagene AI, an emerging leader in the field of AI-based precision medicine for cancer, today announced it raised $21.5 million, comprising $3M in seed funding led by Blumberg Capital and an $18.5M Series A round led by renowned technology-driven cancer medicine investors Larry Ellison, Dr. David Agus, and AI imaging space pioneer Eyal Gura. - The use of AI-based molecular testing in cancer diagnostics is revolutionizing patient care by offering a new level of
Read More
Seven Bridges, USP, Google Cloud to Build A Brazilian Reference Genome
What You Should Know: - Seven Bridges, a bioinformatics ecosystem provider, announced it is collaborating with the University of São Paulo (USP) and Google Cloud, as well as the Associação Genomas Brasil (Brazil Genome Association), to assist the DNA do Brasil (DNABr) project in building a reference genome that represents the genetic diversity of the Brazilian population. - The joint effort will advance unbiased precision medicine for underrepresented populations in Brazil through the
Read More
Golden Valley Memorial Goes Live on MEDITECH Expanse Genomics
What You Should Know: - MEDITECH announces that Golden Valley Memorial Healthcare (GVMH) is their first client to go live on Expanse Genomics, opening the organization’s possibilities for delivering precision medicine by allowing them to analyze and parse genetic results into discrete, actionable data, displayed directly in patient charts. - Providers can order genetic testing directly in Expanse, and the results will be received and stored in a codified format along with full PDF reports
Read More
C2i Genomics Brings Distributed Cancer Monitoring to Cancer Centers Across Europe
What You Should Know: - C2i Genomics, a cancer intelligence company launches its C2inform minimal residual disease (MRD) test across Europe, after obtaining CE-IVD marking in the EU, UK and Switzerland. The company also announced the completion of several clinical trials across the globe, including leading cancer centers in Europe, U.S. and Singapore. - The new clinical data will be presented at the 2022 American Association for Cancer Research (AACR) annual meeting in New Orleans,
Read More
